Cardinal Health income statement

In fiscal 2026, Cardinal Health reported revenue of $254.25bn, up 14.2% on the year before, operating income of $2.61bn (a 1.0% margin) and net income of $1.71bn, or $7.23 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ billions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Cardinal Health: income statement, annual
Fiscal year	2010Jun 2010	2011Jun 2011	2012Jun 2012	2013Jun 2013	2014Jun 2014	2015Jun 2015	2016Jun 2016	2017Jun 2017	2018Jun 2018	2019Jun 2019	2020Jun 2020	2021Jun 2021	2022Jun 2022	2023Jun 2023	2024Jun 2024	2025Jun 2025	2026Jun 2026
Revenue	98.5	102.6	107.6	101.1	91.1	102.5	121.5	130.0	136.8	145.5	152.9	162.5	181.3	205.0	226.8	222.6	254.2
Cost of revenue	—	—	—	—	—	—	115.0	123.4	129.6	138.7	146.1	155.7	174.8	198.1	219.4	214.4	244.5
Gross profit	3.8	4.2	4.5	4.9	5.2	5.7	6.5	6.5	7.2	6.8	6.9	6.8	6.5	6.9	7.4	8.2	9.8
Selling, general and administrative	2.4	2.5	2.7	2.9	3.0	3.2	3.6	3.8	4.6	4.5	4.6	4.5	4.5	4.8	5.0	5.4	6.1
Operating income	1.3	1.5	1.8	1.0	1.9	2.2	2.5	2.1	0.1	2.1	−4.1	0.5	−0.6	0.8	1.2	2.3	2.6
Interest expense	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.3	0.3	0.2	0.2	0.1	0.1	0.1	0.2	0.3
Income before tax	1.2	1.5	1.7	0.9	1.8	2.0	2.3	1.9	−0.2	1.8	−3.8	0.3	−0.8	0.7	1.2	2.1	2.2
Income tax	0.6	0.6	0.6	0.6	0.6	0.8	0.8	0.6	−0.5	0.4	−0.1	−0.3	0.2	0.3	0.3	0.5	0.5
Net income	0.6	1.0	1.1	0.3	1.2	1.2	1.4	1.3	0.3	1.4	−3.7	0.6	−0.9	0.3	0.9	1.6	1.7
Diluted EPS	$1.77	$2.72	$3.06	$0.97	$3.38	$3.62	$4.32	$4.03	$0.81	$4.53	−$12.61	$2.08	−$3.37	$1.26	$3.45	$6.45	$7.23
Diluted shares (average)	361m	353m	349m	344m	345m	335m	330m	320m	315m	301m	293m	294m	279m	262m	247m	242m	237m
EBITDA	1.6	1.8	2.1	1.4	2.3	2.6	3.1	2.8	1.2	3.1	−3.2	1.3	0.1	1.4	2.0	3.1	3.6

US$ billions unless shown otherwise. Fiscal quarters.

Cardinal Health: income statement, quarterly
Quarter	2024 Q3Mar 2024	2024 Q4Jun 2024	2025 Q1Sept 2024	2025 Q2Dec 2024	2025 Q3Mar 2025	2025 Q4Jun 2025	2026 Q1Sept 2025	2026 Q2Dec 2025
Revenue	54.9	59.9	52.3	55.3	54.9	60.2	64.0	65.6
Cost of revenue	52.9	58.0	50.4	53.3	52.8	58.0	61.7	63.2
Gross profit	1.9	1.9	1.9	1.9	2.1	2.2	2.3	2.4
Selling, general and administrative	1.3	1.3	1.3	1.3	1.3	1.5	1.5	1.5
Operating income	0.4	0.4	0.6	0.5	0.7	0.4	0.7	0.7
Interest expense	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1
Income before tax	0.3	0.4	0.5	0.5	0.7	0.4	0.6	0.6
Income tax	0.1	0.2	0.1	0.1	0.2	0.1	0.1	0.2
Net income	0.3	0.2	0.4	0.4	0.5	0.2	0.5	0.5
Diluted EPS	$1.07	—	$1.70	—	—	—	$1.88	—
EBITDA	0.5	0.6	0.8	0.7	0.9	0.6	0.9	0.9

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: CAH vs COR CAH vs MCK CAH vs HSIC

More: Health Care Distributors stocks compared, Health Care sector, rankings of US companies

Figures from Cardinal Health's SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Cardinal Health.